Biogen to acquire RayThera for up to $1bn

Friday, June 19, 2026Salong DebbarmaView original

Biogen is to acquire RayThera, a biotechnology company specialising in small-molecule therapies for immunology, for up to $1bn.

Read the full article on the original site.